Publicaciones (50) Publicaciones de María Victoria García Mediavilla

2024

  1. Idiosyncratic Drug-Induced Liver Injury and Amoxicillin–Clavulanate: Spotlight on Gut Microbiota, Fecal Metabolome and Bile Acid Profile in Patients

    International Journal of Molecular Sciences, Vol. 25, Núm. 13

2023

  1. Enhanced mitochondrial activity reshapes a gut microbiota profile that delays NASH progression

    Hepatology, Vol. 77, Núm. 5, pp. 1654-1669

  2. Erratum: A comparison of the effects of kaempferol and quercetin on cytokine-induced pro-inflammatory status of cultured human endothelial cells (British Journal of Nutrition (2008) 100: 5 (968-976) DOI: 10.1017/S0007114508966083)

    British Journal of Nutrition

2021

  1. Aging, gut microbiota and metabolic diseases: Management through physical exercise and nutritional interventions

    Nutrients, Vol. 13, Núm. 1, pp. 1-21

  2. Long-term effects of bariatric surgery on gut microbiota composition and faecal metabolome related to obesity remission

    Nutrients, Vol. 13, Núm. 8

  3. The synbiotic combination of akkermansia muciniphila and quercetin ameliorates early obesity and NAFLD through gut microbiota reshaping and bile acid metabolism modulation

    Antioxidants, Vol. 10, Núm. 12

2020

  1. Exercise training modulates the gut microbiota profile and impairs inflammatory signaling pathways in obese children

    Experimental and Molecular Medicine, Vol. 52, Núm. 7, pp. 1048-1061

2019

  1. A Network Involving Gut Microbiota, Circulating Bile Acids, and Hepatic Metabolism Genes That Protects Against Non-Alcoholic Fatty Liver Disease

    Molecular Nutrition and Food Research, Vol. 63, Núm. 20

  2. An altered fecal microbiota profile in patients with non-alcoholic fatty liver disease (NAFLD) associated with obesity

    Revista Española de Enfermedades Digestivas, Vol. 111, Núm. 4, pp. 275-282

  3. Beneficial effects of exercise on gut microbiota functionality and barrier integrity, and gut-liver crosstalk in an in vivo model of early obesity and non-alcoholic fatty liver disease

    DMM Disease Models and Mechanisms, Vol. 12, Núm. 5

  4. Functional Interactions between Gut Microbiota Transplantation, Quercetin, and High-Fat Diet Determine Non-Alcoholic Fatty Liver Disease Development in Germ-Free Mice

    Molecular Nutrition and Food Research, Vol. 63, Núm. 8

  5. Study of Master Formulas for Animal Use in a Pharmacy

    Journal of Veterinary and Animal Research, Vol. 2, Núm. 1

2018

  1. Anti-inflammatory, immunomodulatory, and prebiotic properties of dietary flavonoids

    Polyphenols: Prevention and Treatment of Human Disease (Elsevier), pp. 327-345

  2. Aparato respiratorio: ventilación pulmonar

    Sistema respiratorio: métodos, fisioterapia clínica y afecciones para fisioterapeutas (Editorial Médica Panamericana), pp. 339-344

  3. Autophagy as a molecular target of flavonoids underlying their protective effects in human disease

    Current Medicinal Chemistry, Vol. 25, Núm. 7, pp. 814-838

  4. Circulación pulmonar: regulación de la respiración

    Sistema respiratorio: métodos, fisioterapia clínica y afecciones para fisioterapeutas (Editorial Médica Panamericana), pp. 349-352

  5. Hepatitis C virus-inuced steatosis

    Fatty liver disease: a reality with many questions (Eolas), pp. 299-318

  6. Intercambio gaseoso y transporte de gases respiratorios

    Sistema respiratorio: métodos, fisioterapia clínica y afecciones para fisioterapeutas (Editorial Médica Panamericana), pp. 345-348

  7. Intestinal microbiota modulation in obesity-related non-alcoholic fatty liver disease

    Frontiers in Physiology, Vol. 9

  8. Pathogenic mechanisms in non-alcoholic fatty liver disease (NAFLD)

    Fatty liver disease: a reality with many questions (Eolas), pp. 63-83